Patent Oppositions in infection drugs industry

Explore the competitive field of infection drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in infection drugs technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the infection drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the infection drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
A Method For High Level And Stable Gene Transfer In LymphocytesJULIUS MAXIMILIANS UNIVERSITT WRZBURGJul 3, 2026MAX DELBRUCK CENTRUM FUR MOLEKULARE MEDIZIN IN DER HELMHOLTZ GEMEINSCHAFT
Biphenyl Sulfonamide Compounds For The Treatment Of Type Iv Collagen DiseasesTRAVERE THERAPEUTICSJun 30, 2026TEVA PHARMACEUTICAL INDUSTRIES LTD
Pharmaceutical Compositions Comprising CabotegravirVIIV HEALTHCAREJun 19, 2026ELKINGTON AND FIFE
Methods Of Treating Chronic Kidney Disease With DapagliflozinASTRAZENECAJun 17, 2026STADA ARZNEIMITTEL
Methods Of Treating Chronic Kidney Disease With DapagliflozinASTRAZENECAJun 16, 2026BARDEHLE PAGENBERG
Methods Of Treating Chronic Kidney Disease With DapagliflozinASTRAZENECAJun 11, 2026DEVA HOLDING ANONIM SIRKETI
Methods Of Treating Chronic Kidney Disease With DapagliflozinASTRAZENECAJun 9, 2026TEVA PHARMACEUTICAL INDUSTRIES LTD
Methods Of Treating Chronic Kidney Disease With DapagliflozinASTRAZENECAJun 2, 2026AWA DENMARK
Bacteriotherapy For Clostridium Difficile ColitisFERRING MICROBIOMEMay 19, 2026CABINET PLASSERAUD
Methods Of Treating Chronic Kidney Disease With DapagliflozinASTRAZENECAMay 12, 2026SANDOZ

To stay ahead in the competitive infection drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the infection drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Sep 17, 2025Methods Of Treating Chronic Kidney Disease With DapagliflozinASTRAZENECA14
Dec 13, 2023Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARE9
Aug 24, 2022Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses ThereofE R SQUIBB & SONS6
Mar 14, 2018Crystalline Form Of Abacavir That Is Essentially Free Of SolventESTEVE QUMICA5
Dec 4, 2024Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5] Pyrazino [2, 1-B] Oxazepin-8-OlateGILEAD SCIENCES5
Dec 28, 2022Small Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINE BIOLOGICALS SA5
Jun 7, 2023Arginine And Its Use As A T Cell ModulatorINSTITUTE FOR RESEARCH IN BIOMEDICINE4
Sep 23, 2020Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells ActivityINSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALE4
Jul 15, 2020Methods Of Treating Cancer Using Pd-1 Axis Binding Antagonists And Tigit InhibitorsF HOFFMANN LA ROCHE4
Mar 20, 2019Methods For Treating Bowel DiseasesSALIX PHARMACEUTICALS4